Elevated serum lipoprotein(a) levels in young women with endometriosis

Metabolism: Clinical and Experimental

Volumn 46, Issue 7, 1997, Pages 735-739

  Crook, David ^a   Howell, Rosemary ^b   Sidhu, Mandeep ^b   Edmonds, D Keith ^b   Stevenson, John C ^b  

^a Wynn Institute   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMINO ACID SEQUENCE; ARTICLE; ATHEROGENESIS; BINDING SITE; CLINICAL ARTICLE; COMPLEX FORMATION; DRUG RECEPTOR BINDING; ENDOMETRIOSIS; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030793162     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90115-3     Document Type: Article

References (52)

1. Lawn RM: Lipoprotein(a) in heart disease. Sci Am 266:54-60, 1992
2. Maher VMG, Brown BG: Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol 6:229-235, 1995
3. Olive DL, Schwartz LB: Endometriosis. N Engl J Med 328:1759-1769, 1993
4. Rock JA, Markham SM: Pathogenesis of endometriosis. Lancet 340:1264-1271, 1992
5. Sampson J: Peritoneal endometriosis due to dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422-429, 1927
6. Dmowski WP, Steele RW, Baker GF: Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 141:377-383, 1981
7. Halme J: Role of peritoneal inflammation in endometriosis-associated infertility. Ann NY Acad Sci 622:266-274, 1991
8. Crook D, Sidhu M, Seed M, et al: Lp(a) levels in women given danazol, an impeded androgen. Atherosclerosis 92:41-47, 1992
9. Sandholzer C, Hallman DM, Saha N, et al: Effects of the apblipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 86:607-614, 1991
10. Revised American Fertility Society classification of endometriosis. Fertil Steril 43:351-352, 1985
11. Crook D, Godsland IF, Worthington M, et al: A comparative metabolic study of two low estrogen dose oral contraceptives containing gestodene or desogestrel progestins. Am J Obstet Gynecol 169:1183-1189, 1993
12. Warnick G, Albers J: A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65-76, 1978
13. Gidez L, Miller G, Burstein M, et al: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23:1206-1223, 1982
14. Friedewald W, Levy R, Fredrickson D: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
15. Mount J, Kearney E, Rosseneu M, et al: Immunoturbidimetric assays for serum apolipoproteins AI and B using Cobas Bio centrifugal analyser. J Clin Pathol 41:471-474, 1988
16. Boerwinkle E, Menzel HJ, Kraft HG, et al: Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotype to normal lipid variation. Hum Genet 82:73-78, 1989
17. Sandkamp M, Funke H, Schulte H, et al: Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 36:20-23, 1990
18. Kostner GM, Avogaro P, Cazzolato G, et al: Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38:51-61, 1981
19. Gaw A, Hobbs HH: Molecular genetics of lipoprotein(a): New pieces to the puzzle. Curr Opin Lipidol 5:149-155, 1994
20. Rader DJ, Cain W, Ikewaki K, et al: The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in lipoprotein(a) catabolism but due to differences in production rate. J Clin Invest 93:2758-2763, 1994
21. Lackner C, Cohen JC, Hobbs HH: Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 2:933-940, 1993
22. Berg K: A hew serum type system in man - The Lp system. Acta Pathol Microbiol Scand 59:369-382, 1963
23. Rader DJ, Hoeg JM, Brewer HB: Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 120:1012-1025, 1994
24. Dahlen GH: Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108:111-126, 1994
25. Lawn RM, Wade DP, Hammick HE, et al: Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 360:670-672, 1992
26. Mancini FP, Newland DL, Mooser V, et al: Relative contributions of apolipoprotein(a) and apolippprotein-B to the development of fatty lesions in the proximal aorta of mice. Arterioscler Thromb Vasc Biol 15:1911-1916, 1995
27. Thompson GR, Maher VMG, Matthews S, et al: Familial Hypercholesterolaemia Regression Study: A randomised trial of low density lipoprotein apheresis. Lancet 345:811-816, 1995
28. Jauhiainen M, Koskinen P, Ehnholm C, et al: Lipoprotein(a) and coronary heart disease risk: A nested case-control study of Helsinki Heart Study participants. Atherosclerosis 89:59-67, 1991
29. Ridker PM, Hennekens CH, Stampfer MJ: A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 270:2195-2199, 1993
30. Parra H-J, Luyeye I, Bouramoue C, et al: Black-white differences in serum Lp(a) lipoprotein levels. Clin Chim Acta 167:27-31, 1987
31. Maeda S, Abe M, Seishima M, et al: Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 78:145-150, 1989
32. Slunga L, Johnson O, Dahlen GH, et al: Lipoprotein(a) and acute-phase proteins in acute myocardial infarction. Scand J Clin Lab Med 52:95-101, 1992
33. Niendorf A, Stang A, Beseigel U, et al: Elevated lipoprotein(a) levels in patients with acute myoblastic leukemia decrease after successful chemotherapeutic treatment. Clin Invest 70:683-685, 1992
34. Rantapaa-Dahlqvist S, Wallberg-Jonsson S, Dahlen G: Lipoprotein(a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 50:109-113, 1991
35. Short CD, Durrington PN, Mallick NB, et al: Serum lipoprotein(a) in men with proteinuria due to idiopathic membranous nephropathy. Nephrol Dial Transplant 7:109-113, 1992 (suppl 1)
36. Anwar N, Bhatnager D, Durrington PN, et al: A cross-sectional study of cardiovascular risk factors in patients on renal replacement with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 8:71-74, 1993
37. Ledue TB, Neveux LM, Palomaki GE, et al: The relationship between serum levels of lipoprptein(a) and proteins associated with the acute phase response. Clin Chim Acta 223:73-83, 1993
38. Wade DP, Clarke JG, Lindhal GE, et al: 5′ Control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 90:1369-1373, 1993
39. Frazer KA, Narla G, Zhang JL, et al: The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nat Genet 56:287-293, 1995
40. Halme J, Becker S, Hammond MG, et al: Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am J Obstet Gynecol 145:333-337, 1983
41. Hill JA, Faris HMP, Schiff I, et al: Characterization of leucocyte subpopulations in the peritoneal fluid of women with endometriosis. Fertil Steril 50:216-222, 1988
42. Fakih H, Baggett B, Holtz G, et al: Interleukin-1: A possible role in the infertility associated with endometriosis. Fertil Steril 47:213-217, 1987
43. Badawy SZ, Cuenca V, Stitzel A, et al: Immune rosettes of T- and B-lymphocytes in infertile women with endometriosis. J Reprod Med 32:194-197, 1987
44. Boutten A, Dehoux M, Edelman P, et al: IL6 and acute phase plasma proteins in peritoneal fluid of women with endometriosis. Clin Chim Acta 210:187-195, 1992
45. Buyalos RP, Funari VA, Azziz R, et al: Elevated interleukin-6 levels in peritioneal fluid of patients with pelvic pathology. Fertil Steril 58:302-306, 1992
46. Lim YT, Schenken RS: Interleukin-6 in experimental endometriosis. Fertil Steril 59:912-916, 1993
47. Imaizumi E, Hirata J, Tode T, et al: Interleukin-6 production in endometriosis. Nippon Sanka Fujinka Gakkai Zasshi 45:415-422, 1993
48. El-Roeiy A, Dmowski WP, Gleicher N: Danazol but not gonadotrophin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fertil Steril 50:864-871, 1988
49. Hardardóttir I, Grünfeld C, Feingold KR: Effects of endotoxins and cytokines on lipid metabolism. Curr Opin Lipidol 5:207-215, 1994
50. Wheeler JM: Epidemiology of endometriosis-related infertility. J Reprod Med 34:41-46, 1989
51. Mahmood TA, Templeton A: Prevalence and genesis of endometriosis. Hum Reprod 6:544-549, 1991
52. Grainger DJ, Kemp PR, Metcalfe JC, et al: The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1:74-79, 1995